Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Heltai

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Cytometry|January 1, 1997
Quantitative cytometry of MHC class I digestion from living cellsG Galati, C Arcelloni, R Paroni, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1991
Recombinant interleukin-2 and lymphokine-activated killer cells in renal cancer patients: II. Characterization of cells cultured ex vivo and their contribution to the in vivo immunomodulationC Fortis, E Ferrero, M Biffi, et al.
International Immunology|October 24, 1998
Age-related modifications of the human alphabeta T cell repertoire due to different clonal expansions in the CD4+ and CD8+ subsetsA Wack, A Cossarizza, S Heltai, et al.
Human Gene Therapy|July 3, 1998
Human melanoma cells transfected with the B7-2 co-stimulatory molecule induce tumor-specific CD8+ cytotoxic T lymphocytes in vitroM A Imro, P Dellabona, S Manici, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 22, 1999
Generation of nitric oxide by the inducible nitric oxide synthase protects gamma delta T cells from Mycobacterium tuberculosis-induced apoptosisC Sciorati, P Rovere, M Ferrarini, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 15, 1996
CD95 engagement releases calcium from intracellular stores of long term activated, apoptosis-prone gammadelta T cellsP Rovere, E Clementi, M Ferrarini, et al.
Clinical and Experimental Immunology|October 1, 1990
Signal requirements for activation of leukaemic T cells from a chronic lymphocytic leukaemia (T-CLL)M R Zocchi, A Poggi, S Heltai, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1990
Recombinant interleukin-2 and lymphokine-activated killer cells in renal cancer patients: I. Phenotypic and functional analysis of the peripheral blood mononuclear cellsC Fortis, E Ferrero, C Besana, et al.
Tumori|August 31, 1991
Autoimmune thyroiditis following interleukin-2 and LAK cell therapy for metastatic renal cell carcinoma: correlation with tumor regressionC Besana, M G Sabbadini, C Corti, et al.
Arthritis and Rheumatism|March 4, 1998
Apoptotic cell clearance in systemic lupus erythematosus. II. Role of beta2-glycoprotein IA A Manfredi, P Rovere, S Heltai, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Cytometry|January 1, 1997
Quantitative cytometry of MHC class I digestion from living cellsG Galati, C Arcelloni, R Paroni, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1991
Recombinant interleukin-2 and lymphokine-activated killer cells in renal cancer patients: II. Characterization of cells cultured ex vivo and their contribution to the in vivo immunomodulationC Fortis, E Ferrero, M Biffi, et al.
International Immunology|October 24, 1998
Age-related modifications of the human alphabeta T cell repertoire due to different clonal expansions in the CD4+ and CD8+ subsetsA Wack, A Cossarizza, S Heltai, et al.
Human Gene Therapy|July 3, 1998
Human melanoma cells transfected with the B7-2 co-stimulatory molecule induce tumor-specific CD8+ cytotoxic T lymphocytes in vitroM A Imro, P Dellabona, S Manici, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 22, 1999
Generation of nitric oxide by the inducible nitric oxide synthase protects gamma delta T cells from Mycobacterium tuberculosis-induced apoptosisC Sciorati, P Rovere, M Ferrarini, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 15, 1996
CD95 engagement releases calcium from intracellular stores of long term activated, apoptosis-prone gammadelta T cellsP Rovere, E Clementi, M Ferrarini, et al.
Clinical and Experimental Immunology|October 1, 1990
Signal requirements for activation of leukaemic T cells from a chronic lymphocytic leukaemia (T-CLL)M R Zocchi, A Poggi, S Heltai, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1990
Recombinant interleukin-2 and lymphokine-activated killer cells in renal cancer patients: I. Phenotypic and functional analysis of the peripheral blood mononuclear cellsC Fortis, E Ferrero, C Besana, et al.
Tumori|August 31, 1991
Autoimmune thyroiditis following interleukin-2 and LAK cell therapy for metastatic renal cell carcinoma: correlation with tumor regressionC Besana, M G Sabbadini, C Corti, et al.
Arthritis and Rheumatism|March 4, 1998
Apoptotic cell clearance in systemic lupus erythematosus. II. Role of beta2-glycoprotein IA A Manfredi, P Rovere, S Heltai, et al.
Pageof 3